A phase IIb, randomised, double-blind, placebo controlled, dose finding study assessing the haemodynamic safety and 'at home' efficacy of inhaled VR004 [apomorphine] in patients with erectile dysfunction (ED)

Trial Profile

A phase IIb, randomised, double-blind, placebo controlled, dose finding study assessing the haemodynamic safety and 'at home' efficacy of inhaled VR004 [apomorphine] in patients with erectile dysfunction (ED)

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Jul 2016

At a glance

  • Drugs Apomorphine (Primary)
  • Indications Erectile dysfunction
  • Focus Therapeutic Use
  • Sponsors Vectura
  • Most Recent Events

    • 01 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top